Several studies are currently underway to help increase our understanding of the causes of diabetes and its complications, and to develop better strategies to prevent and manage its complications. Our Diabetes & Endocrinology Clinical Research Unit (DECRU) offers our patients and other volunteers the opportunity to participate in state-of-the-art phase I, II, III, and IV clinical trials with investigational medications for the treatment of diabetes and related metabolic disorders.
For further information about our DECRU and our clinical trials please contact:
Clinical Trial Administrator , Diabetes & Endocrine Clinical Research Unit
510 20th Street South
Birmingham, AL 35294
Phone 205-934-4112; Fax 205-934-4379